• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

Drug Delivery Business

  • Clinical Trials
  • Research & Development
  • Drug-Device Combinations
  • FDA
  • Pharmaceuticals
  • Policy

ADA 2023

Dexcom CCO Teri Lawver says new sensor is ‘first step’ to expand addressable market

July 5, 2023 By Sean Whooley

Teri Lawver Dexcom CCO

Teri Lawver joined Dexcom (Nasdaq:DXCM) as chief commercial officer just as the company got set for a massive commercial undertaking. The FDA cleared the company’s next-generation Dexcom G7 continuous glucose monitor (CGM) in December 2022. One month later, Lawver assumed the position of CCO. Within about a month, she was set to oversee the U.S. launch […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, Dexcom

The biggest stories from the American Diabetes Association (ADA) 2023 Scientific Sessions

June 30, 2023 By Sean Whooley

American Diabetes Association ADA 2023 Medtronic MiniMed 780G Insulet Omnipod 5 Senseonics Eversense E3 GLP-1s

As it does every year, this past week, the American Diabetes Association convened its Scientific Sessions to bring together leaders in the diabetes space. At last year’s event, next-generation technologies from the big hitters took the spotlight. The 83rd iteration this past week produced a range of new studies, product updates and positive news for […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Pediatrics, Pharmaceuticals, Surgical, Technology, Wall Street Beat Tagged With: abbott, ADA 2023, American Diabetes Association, Bigfoot Biomedical, Dexcom, Eli Lilly & Co., Fractyl Health, Insulet, Medtronic, Novo Nordisk, Senseonics, Sernova Inc, Vida Health, Virta Health

Study shows health equity impact from Virta Health diabetes reversal platform

June 27, 2023 By Sean Whooley

Virta Health

Virta Health announced that real-world data for its diabetes reversal platform demonstrated narrowing gaps in care. The company shared its data at the American Diabetes Association’s 83rd Scientific Sessions. The research highlighted its impact on health equity. It demonstrated significant health improvement and medication reduction for members in the most and least disadvantaged U.S. neighborhoods. […]

Filed Under: Clinical Trials, Diabetes, Technology Tagged With: ADA 2023, American Diabetes Association, Virta Health

Vida Health reports positive data for virtual diabetes program in low-income populations

June 27, 2023 By Sean Whooley

A person uses the Vida Health digital diabetes management program on their smartphone.

Vida Health announced new research demonstrating significantly lowered A1C levels with its virtual cardiometabolic program. The research highlighted use of the program in low-income Medicare Advantage members. Significantly lowered A1C levels even occurred in areas with limited income and food access. Vida Health’s study compared its members living in areas of low income and low […]

Filed Under: Clinical Trials, Diabetes, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, American Diabetes Association, Vida Health

Studies back Fractyl Health diabetes reversal procedure, gene therapy

June 26, 2023 By Sean Whooley

This is the logo of Fractyl Health.

Fractyl Health announced multiple studies supporting its programs for the reversal and treatment of diabetes. Lexington, Massachusetts-based Fractyl reported data from its Revitalize 1 pivotal study and its Rejuva program. Revitalize 1 evaluates the company’s Revita endoscopic ablation procedure to reverse diabetes. Rejuva evaluates a targeted pancreatic gene therapy. The company presented its results at […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Surgical Tagged With: ADA 2023, American Diabetes Association, Fractyl Health

Data supports safety and accuracy of Senseonics 365-day CGM

June 26, 2023 By Sean Whooley

Marketing image Senseonics Eversense E3 Ascensia Diabetes Care

Senseonics (NYSE:SENS) today announced positive clinical data highlighting the effectiveness of its Eversense continuous glucose monitor (CGM). Germantown, Maryland-based Senseonics presented two studies on its latest-generation Eversense E3 at the American Diabetes Association 83rd Scientific Session. The 180-day implantable CGM received FDA approval in February of last year. The sensor is fully implantable and requires just […]

Filed Under: Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, American Diabetes Association, Senseonics

Once-weekly insulin from Novo Nordisk meets clinical trial endpoints

June 26, 2023 By Sean Whooley

Novo Nordisk - updated logo

Novo Nordisk announced data that met primary endpoints from clinical trials investigating its once-weekly basal insulin icodec. While meeting primary endpoints, the studies also demonstrated reduced injections. These injections decreased from seven to one per week with once-daily basal insulin. Novo Nordisk presented results at the 83rd Annual Scientific Sessions of the American Diabetes Association […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured Tagged With: ADA 2023, American Diabetes Association, Novo Nordisk

Abbott, ADA partner on therapeutic nutrition program for people with diabetes

June 26, 2023 By Sean Whooley

Abbott FreeStyle Libre 3 Sensor and mobile app

Abbott (NYSE:ABT) and the American Diabetes Association (ADA) announced a collaboration to improve nutrition for people with diabetes. The duo aims to help better understand how diabetes technology, like continuous glucose monitoring (CGM), can help. They hope to aid people with diabetes make more informed decisions about their food and activity. Abbott develops a family […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: abbott, ADA 2023, American Diabetes Association

Dexcom aims to bring new glucose sensor to the market for people who don’t use insulin

June 23, 2023 By Sean Whooley

Dexcom updated logo

Dexcom (Nasdaq:DXCM) today unveiled its strategy to expand access to its glucose-sensing technology for millions around the world. San Diego-based Dexcom held an Investor Day event in which it revealed plans to bring a new product to market in the U.S. in 2024. The company designed its new product for people who don’t use insulin […]

Filed Under: Business/Financial News, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, American Diabetes Association, Dexcom

New data supports Medtronic MiniMed 780G automated insulin delivery system for children

June 23, 2023 By Sean Whooley

Medtronic MiniMed 780G with Guardian 4 sensor and seven-day infusion set

Medtronic (NYSE:MDT) today announced positive clinical and real-world data supporting its MiniMed 780G automated insulin delivery system. The latest data sets evaluated the recently FDA-approved system across a wide range of users. They looked at younger patients, those not meeting glycemic goals and individuals using simplified meal announcement technology. Medtronic presented these results at the 83rd […]

Filed Under: Business/Financial News, Clinical Trials, Diabetes, Drug-Device Combinations, Featured, Patient Monitoring, Technology Tagged With: ADA 2023, American Diabetes Association, Medtronic

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“ddb
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in drug delivery.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Footer

Drug Delivery Business News Logo

MassDevice Medical NETWORK

MassDevice
DeviceTalks
Medical Tubing + Extrusion
Medical Design & Outsourcing
MedTech100 Index
Drug Discovery & Development
Pharmaceutical Processing World
Medical Design Sourcing
R&D World

DRUG DELIVERY BUSINESS NEWS

Subscribe to Drug Delivery’s E-Newsletter
Advertise with us
About
Contact us
Privacy
Listen to our Weekly Podcasts

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy | RSS